{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:51:12Z","timestamp":1784735472761,"version":"3.55.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,2]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Late-stage cancer patients often experience severe pain due to bone metastasis, caused by structural damage and cancer-induced inflammation. Hyaluronan, known to alleviate pain by blocking the TRVP1 calcium channel, faces limitations due to its high molecular weight. However, 35\u2009kDa low molecular weight hyaluronan fragment (HA35) have shown promise in relieving various pains, including cancer-related pain. Nonetheless, evidence regarding their efficacy in bone metastasis pain remains scarce.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients concerns:<\/jats:title>\n            <jats:p>A 52-year-old female with a rectal malignant tumor and multiple secondary tumors in the sacrum and lungs, accompanied by bone metastasis pain. Despite undergoing radiotherapy, her pain relief was unsatisfactory. Before treatment with HA35, her numerical rating scale score was 10, severely affecting her sleep, appetite, and daily activities.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>The patient was diagnosed with rectal malignant tumor with multiple metastases, presenting symptoms such as sacral metastasis pain, anal pain, lower limb pain, and anterior abdominal pain. Sacral metastasis pain and lower limb pain indicated a clear diagnosis of bone metastasis pain.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Treatment involved subcutaneous injection into the deep fat tissue layer of the abdomen. A subcutaneous injection of 100\u2009mg\/5\u2009mL of HA35 was administered once into the deep fat tissue of the abdomen, with subsequent injections repeated every 3 days.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Following 1 injection, the patient\u2019s pain score decreased to 6 points within 20 minutes, providing 40% pain relief. After 40 minutes, the score further dropped to 4 points, with 60% pain relief. After 50 injections, pain was consistently controlled at around 3 points.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons subsections:<\/jats:title>\n            <jats:p>Subcutaneous injection of HA35 into the abdominal fat tissue effectively alleviates pain in cancer and bone metastasis patients resistant to conventional treatments. Additionally, it helps alleviate anxiety and fatigue, and improves diet and sleep, thereby offering crucial palliative care for advanced cancer patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000039145","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T17:30:54Z","timestamp":1722619854000},"page":"e39145","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Low molecular weight 35\u2009kDa hyaluronan fragment HA35 in the treatment of bone metastasis pain: A case report"],"prefix":"10.1097","volume":"103","author":[{"given":"Zongchun","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Radiotherapy, Qingdao Cancer Hospital, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of anesthesiology, Hynaut Laboratories, Hynaut Group, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Treger","sequence":"additional","affiliation":[{"name":"DeWitt Daughtry Family Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4283-189X","authenticated-orcid":false,"given":"Mizhou","family":"Hui","sequence":"additional","affiliation":[{"name":"Department of anesthesiology, Hynaut Laboratories, Hynaut Group, Qingdao, China"},{"name":"Pharmaceutical Manufacture Department, Nakhia Impex Pharmaceutical Co., Ltd., Ulaanbaatar, Mongolia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","first-page":"e3286","article-title":"Pain management in metastatic bone disease: a literature review.","volume":"10","author":"Ahmad","year":"2018","journal-title":"Cureus"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.3390\/cancers13164229","article-title":"Recent advances in the treatment of bone metastases and primary bone tumors: an up-to-date review.","volume":"13","author":"B\u0103dil\u0103","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/SPC.0000000000000263","article-title":"Use of corticosteroids for pain control in cancer patients with bone metastases: a comprehensive literature review.","volume":"11","author":"Lim","year":"2017","journal-title":"Curr Opin Support Palliat Care"},{"issue":"S1","key":"R4-20250503","first-page":"S233","article-title":"Corticosteroids: review of the history, the effectiveness, and adverse effects in the treatment of joint pain.","volume":"24","author":"Stone","year":"2021","journal-title":"Pain Physician"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"721357","DOI":"10.3389\/fpain.2021.721357","article-title":"Opioids and chronic pain: an analytic review of the clinical evidence.","volume":"2","author":"Nadeau","year":"2021","journal-title":"Front Pain Res (Lausanne)"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0304-3959(02)00040-4","article-title":"Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain.","volume":"100","author":"Walker","year":"2002","journal-title":"Pain"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semradonc.2022.11.004","article-title":"Radiation therapy for painful bone metastases: fractionation, recalcification, and symptom control.","volume":"33","author":"Tseng","year":"2023","journal-title":"Semin Radiat Oncol"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"1133828","DOI":"10.3389\/fonc.2023.1133828","article-title":"Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials.","volume":"13","author":"Lu","year":"2023","journal-title":"Front Oncol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/JIR.S393495","article-title":"Anti-inflammatory effects of the 35\u2009kDa hyaluronic acid fragment (B-HA\/HA35).","volume":"16","author":"Jia","year":"2023","journal-title":"J Inflamm Res"},{"key":"R10-20250503","first-page":"131","article-title":"Injection of 35\u2009kDa hyaluronan fragment, alleviates pain associated with radiotherapy for treatment of colorectal and rectal cancer.","volume":"1","author":"Dashnyam","year":"2023","journal-title":"Pharmacol Pharmacogenom"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"e14906","DOI":"10.1111\/iwj.14906","article-title":"A clinical study of the local injection of a freshly manufactured 35\u2009kDa hyaluronan fragment for treating chronic wounds.","volume":"21","author":"Treger","year":"2024","journal-title":"Int Wound J"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3325\/cmj.2021.62.270","article-title":"The pathogenesis of bone metastasis in solid tumors: a review.","volume":"62","author":"Vi\u010di\u0107","year":"2021","journal-title":"Croat Med J"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.2147\/JPR.S371337","article-title":"The burden of metastatic cancer-induced bone pain: a narrative review.","volume":"15","author":"Colosia","year":"2022","journal-title":"J Pain Res"},{"key":"R14-20250503","first-page":"97","article-title":"Characterization, bioactivity, and biodistribution of 35\u2009kDa hyaluronan fragment.","volume":"14","author":"Gantumur","year":"2024","journal-title":"Life (Basel)"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.1038\/ncomms9095","article-title":"Hyaluronan modulates TRPV1 channel opening, reducing peripheral nociceptor activity and pain.","volume":"6","author":"Caires","year":"2015","journal-title":"Nat Commun"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1177\/10781552231189706","article-title":"Utilization of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 scale for evaluation of quality of life among cancer patients treated with chemotherapy: a hospital-based observational study.","volume":"30","author":"Gudhoor","year":"2024","journal-title":"J Oncol Pharm Pract"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3390\/nu11051135","article-title":"Safety of hyaluronan 35 in healthy human subjects: a pilot study.","volume":"11","author":"Bellar","year":"2019","journal-title":"Nutrients"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:12:53Z","timestamp":1746317573000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":17,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039145","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}